Annual Non Current Assets
$125.45 M
+$82.15 M+189.71%
December 1, 2024
Summary
- As of March 13, 2025, FDMT annual long term assets is $125.45 million, with the most recent change of +$82.15 million (+189.71%) on December 1, 2024.
- During the last 3 years, FDMT annual non current assets has risen by +$28.25 million (+29.06%).
- FDMT annual non current assets is now at all-time high.
Performance
FDMT Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$125.45 M
+$32.18 M+34.50%
December 1, 2024
Summary
- As of March 13, 2025, FDMT quarterly long term assets is $125.45 million, with the most recent change of +$32.18 million (+34.50%) on December 1, 2024.
- Over the past year, FDMT quarterly non current assets has increased by +$57.97 million (+85.90%).
- FDMT quarterly non current assets is now at all-time high.
Performance
FDMT Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
FDMT Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +189.7% | +85.9% |
| 3 y3 years | +29.1% | +275.9% |
| 5 y5 years | +2090.9% | +275.9% |
FDMT Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +203.5% | at high | +275.9% |
| 5 y | 5-year | at high | +2110.6% | at high | +2135.0% |
| alltime | all time | at high | +4347.1% | at high | +4224.4% |
4D Molecular Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $434.93 M(+46.6%) | $125.45 M(+34.5%) |
| Sep 2024 | - | $93.27 M(+38.2%) |
| Jun 2024 | - | $67.48 M(-28.4%) |
| Mar 2024 | - | $94.30 M(+117.8%) |
| Dec 2023 | $296.59 M(+34.5%) | $43.30 M(+29.8%) |
| Sep 2023 | - | $33.37 M(-3.9%) |
| Jun 2023 | - | $34.73 M(-6.1%) |
| Mar 2023 | - | $36.98 M(-10.5%) |
| Dec 2022 | $220.51 M | $41.34 M(-13.3%) |
| Sep 2022 | - | $47.69 M(-15.5%) |
| Jun 2022 | - | $56.41 M(-31.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $81.88 M(-15.8%) |
| Dec 2021 | $256.28 M(-9.3%) | $97.21 M(+29.8%) |
| Sep 2021 | - | $74.89 M(+1111.3%) |
| Jun 2021 | - | $6.18 M(+10.1%) |
| Mar 2021 | - | $5.61 M(-1.1%) |
| Dec 2020 | $282.66 M(+438.3%) | $5.67 M(+0.3%) |
| Sep 2020 | - | $5.66 M(-1.2%) |
| Dec 2019 | $52.51 M(-44.2%) | $5.73 M(+13.3%) |
| Jun 2019 | - | $5.05 M(+74.3%) |
| Dec 2018 | $94.07 M(+284.0%) | $2.90 M |
| Dec 2017 | $24.50 M | - |
FAQ
- What is 4D Molecular Therapeutics annual long term assets?
- What is the all time high annual non current assets for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics annual non current assets year-on-year change?
- What is 4D Molecular Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics quarterly non current assets year-on-year change?
What is 4D Molecular Therapeutics annual long term assets?
The current annual non current assets of FDMT is $125.45 M
What is the all time high annual non current assets for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high annual long term assets is $125.45 M
What is 4D Molecular Therapeutics annual non current assets year-on-year change?
Over the past year, FDMT annual long term assets has changed by +$82.15 M (+189.71%)
What is 4D Molecular Therapeutics quarterly long term assets?
The current quarterly non current assets of FDMT is $125.45 M
What is the all time high quarterly non current assets for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high quarterly long term assets is $125.45 M
What is 4D Molecular Therapeutics quarterly non current assets year-on-year change?
Over the past year, FDMT quarterly long term assets has changed by +$57.97 M (+85.90%)